Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2005
10/05/2005EP1582217A1 Method of obtaining conjugate vaccines and vaccine compositions containing same
10/05/2005EP1582212A1 Intravitreally-injectable solution for the treatment of vitreous haemorrhages
10/05/2005EP1582210A2 Compositions and methods for treating or preventing surgical adhesions
10/05/2005EP1582206A1 Water-soluble composition containing coenzyme q10
10/05/2005EP1582205A2 Agglomerated hydrophilic complexes with multi-phasic release characteristics
10/05/2005EP1582196A2 Translucent nanoemulsion, production method, and uses thereof in the cosmetic, dermatological and/or ophthalmological fields.
10/05/2005EP1582105A1 Method of inhibiting water content variation of composition and use thereof
10/05/2005EP1581809A2 Nk cell receptor conjugates for treating malignancies
10/05/2005EP1581790A2 Peptides that home to tumor lymphatic vasculature and methods of using same
10/05/2005EP1581653A2 Targeted double stranded rna mediated cell killing
10/05/2005EP1581649A2 Binding agents which inhibit myostatin
10/05/2005EP1581615A2 Peptide conjugated anti-cancer prodrugs
10/05/2005EP1581583A1 Multi-arm polypeptide-poly(ethylene glycol) block copolymers as drug delivery vehicles
10/05/2005EP1581582A1 Thiol-selective water-soluble polmer derivatives
10/05/2005EP1581274A1 Injectable gel-forming compositions based on cross-linked and non-cross-linked polymers and the use thereof
10/05/2005EP1581260A2 Polymeric reagents comprising a ketone or a related functional group
10/05/2005EP1581258A1 Pharmaceutical formulation and a method of making same
10/05/2005EP1581255A1 An acqueous pharmaceutical formulation comprising the thrombin inhibitor melagatran and use of the formulation in the manufacture of a medicament for use by nasal administration in treating thromboembolism
10/05/2005EP1581250A2 Oral formulations for proteins and polypeptides
10/05/2005EP1581242A2 Compositions and methods for modifying toxic effects of proteinaceous compounds
10/05/2005EP1581226A1 Inclusion complex of anti-tubercular rifampicin with beta-cyclodextrin or 2-hydroxypropyl beta-cyclodextrin and a process for producing the same
10/05/2005EP1581218A1 Epothilone analogs for site specific delivery in the treatment of proliferative diseases
10/05/2005EP1581196A1 Acid labile drug compositions
10/05/2005EP1581192A1 Improved formulations containing substituted imidazole derivatives
10/05/2005EP1581181A2 Controlled release depot formulations
10/05/2005EP1581156A2 Gilsonite derived pharmaceutical delivery compositions and methods
10/05/2005EP1511475B1 A herbal molecule as potential anti-leukemic drug
10/05/2005EP1507851B1 Method for assembling sub units into capsoides
10/05/2005EP1368007B1 Coating and binding agent for pharmaceutical formulations with improved storage stability
10/05/2005EP1339393B1 A method for restoring the fat-pad
10/05/2005EP1309353B1 Flavone-containing plant extract solutions having improved storage and heat stability
10/05/2005EP1251874B1 Stabilised pharmaceutical compositions and process for their preparation comprising an antibiotic and an expectorant
10/05/2005EP1133279B1 Method of producing vitamin powders
10/05/2005EP1084693B1 Alpha-hydroxy fatty acid derivatives and composition for external use containing the same
10/05/2005EP0929234B2 Tablets containing a sweetening mixture
10/05/2005CN1678524A Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate
10/05/2005CN1678367A Transdermal drug delivery devices having coated microprotrusions
10/05/2005CN1678353A New anti-cancer compounds
10/05/2005CN1678352A Adhesive patch
10/05/2005CN1678351A Adhesive patch
10/05/2005CN1678348A Compositions and methods for therapeutic treatment
10/05/2005CN1678342A Treatment for eye disorder
10/05/2005CN1678334A New plant based agents as bioavailability/bioefficacy enhancers for drugs and nutraceuticals
10/05/2005CN1678318A Medicament compositions based on tiotropium salts and on salmeterol salts
10/05/2005CN1678309A Tropical formulation comprising at least 5% of metronidazole in white petrolatum and its use in the anal and rectal region
10/05/2005CN1678308A Indometacin preparation for external use
10/05/2005CN1678301A Pasting agent
10/05/2005CN1678299A Composition based on triethyl citrate for the treatment of bacterial infections of the skin
10/05/2005CN1678294A Multicomponent pharmaceutical dosage form
10/05/2005CN1678292A Coating suspensions (comprising osmopolymers, osmagents) for forming an expandable osmotic composition in controlled release dosage forms as well as the corresponding method for providing this osmotic
10/05/2005CN1678291A Oral dosage from comprising a liquid active agent formulation and controlling release thereof by an expandable osmotic composition
10/05/2005CN1678290A Dosage forms for increasing the solubility of slow releas drugs
10/05/2005CN1678288A Branched alcohol-based personal care compositions
10/05/2005CN1676525A Hydrophilic polymer-thunder good vine extract binding substance and its medicinal composition
10/05/2005CN1676124A Antibody chemotherapy-medicine
10/05/2005CN1676122A Hard-soluble medicnie release-controlled formulation
10/05/2005CN1676120A Method for preparing hard-soluble gel formulation
10/05/2005CN1221281C Oral, nasal and pulmonary dosage formulations of copolymer1
10/05/2005CN1221249C Injectable aqueous dispersions of propofol
10/05/2005CN1221248C Preparation method for antibiotics composition
10/05/2005CN1221237C Composition for treatment of scars skin disease
10/05/2005CN1221214C Apparatus and method for making gas-filled utricle of optimal size
10/05/2005CN1221190C Composition and method for smoke detoxification
10/04/2005USRE38813 chemically stable skin care compositions comprising a water-in-oil emulsion and certain retinoids; retinol (Vitamin A alcohol), retinal (Vitamin A aldehyde), retinyl acetate, retinyl palmitate and mixtures thereof
10/04/2005US6951939 Multivalent platform molecules comprising high molecular weight polyethylene oxide
10/04/2005US6951885 Pharmaceutical composition
10/04/2005US6951846 Comprises artesunic acid complexed with cyclodextrins, which shields peroxide portion of artemisinin backbone from hydrolytic decomposition; for treatment of malaria
10/04/2005US6951842 solubilizing compound comprising a guanidinium group provides high concentrations of soluble insulin-like growth factor at pH 5 to 9 and at refrigerated temperatures
10/04/2005US6951841 Bioavailability; side effect reduction
10/04/2005US6951658 administering mixtures of animal oils, lioleic acid, arginine, pyroglutamic acid, methyl vitamin B12 and calcium, for prophylaxis of neurodegenative diseases
10/04/2005US6951657 Particles coated with granulated crystalline ibuprofen
10/04/2005US6951655 Comprises liposome core containing drugs (insulin) encapsulated within fatty acid membrane
10/04/2005US6951654 Intravaginal drug delivery devices for the administration of an antimicrobial agent
10/04/2005US6951642 Water-in-oil emulsions with anionic groups, compositions, and methods
10/04/2005CA2117761C Pharmaceutical compositions containing il-6
09/2005
09/29/2005WO2005090579A1 Modified bouganin proteins, cytotoxins and methods and uses thereof
09/29/2005WO2005090570A1 Therapeutic compositions and methods for treating diseases that involve angiogenesis
09/29/2005WO2005090461A2 Thermoplastic films and methods for making
09/29/2005WO2005090408A1 Native plant cell wall compositions and methods of use
09/29/2005WO2005090395A2 Methods for increasing protein polyethylene glycol (peg) conjugation
09/29/2005WO2005090393A2 Multimeric protein toxins to target cells having multiple identifying characteristics
09/29/2005WO2005089926A1 Method for producing coated fine particles
09/29/2005WO2005089822A1 Medicine/gene leaching type stent
09/29/2005WO2005089809A2 Calicheamicin conjugation by antibody deglycosylation
09/29/2005WO2005089808A2 Antibody calicheamicin conjugates
09/29/2005WO2005089807A2 Antibody calicheamicin conjugates for passive targeting
09/29/2005WO2005089806A1 Cream-gel containing ivermectin
09/29/2005WO2005089805A2 Polymer-based compositions and conjugates of hiv entry inhibitors
09/29/2005WO2005089797A2 Support system in the form of protein-based nanoparticles for the cell-specific enrichment of pharmaceutically active substances
09/29/2005WO2005089796A1 Site-specific chemical modification of hiv gp41-derived peptides
09/29/2005WO2005089768A1 Intranasal benzodiazepine compositions
09/29/2005WO2005089716A1 Preparation with elevated content
09/29/2005WO2005089715A1 Ophthalmic solution comprising sodium carboxymethylcellulose and hydroxypropylmethylcellulose
09/29/2005WO2005089714A1 Emulsion stabilizer
09/29/2005WO2005089503A2 Cd4-igg2 formulations
09/29/2005WO2005089224A2 iRNA AGENTS TARGETING VEGF
09/29/2005WO2005074460A3 Methods of enhancing immune response in the intradermal compartment and compounds useful in the methods
09/29/2005WO2005051976A3 Protein and peptide ligation processes and one-step purification processes
09/29/2005WO2005042741A3 Methods and compositions for treating 5alpha-reductase type 1 and type 2 dependent conditions
09/29/2005WO2005041925A3 Compositions and dosage forms for enhanced absorption
1 ... 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 ... 1712